Key Developments: Medidata Solutions Inc (MDSO.O)
68.11USD
21 May 2013
$-2.30 (-3.27%)
$71.98
$70.24
$70.54
$67.29
411,082
216,674
$75.22
$26.74
Latest Key Developments (Source: Significant Developments)
Medidata Solutions Inc Raises FY 2013 Guidance; Issues Q2 2013 Guidance Above Analysts' Estimates
Medidata Solutions Inc announced that for fiscal 2013, it now expects revenues between $270.0 and $274.0 million, non-GAAP operating income between $61.0 and $64.0 million, based on current estimates, this would equate to GAAP operating income between $23.0 and $26.0 million and adjusted non-GAAP net income, which includes the tax affected impact primarily from stock-based compensation and amortization at a 40% effective tax rate, between $31.5 and $34.5 million. This would equate to GAAP net income between $13.5 and $16.5 million for 2013. For the second quarter of 2013, the Company expects revenues between $65.5 and $67.0 million, non-GAAP operating income between $14.0 and $15.0 million, based on current estimates, this would equate to GAAP operating income between $3.5 and $4.5 million and adjusted non-GAAP net income, which includes the tax affected impact primarily from stock-based compensation and amortization at a 40% effective tax rate, between $7.0 and $8.0 million. Based on current estimates, this would equate to GAAP net income between $1.5 and $2.5 million for the second quarter. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $267.2 million, EBIT of $46.2 million and net income of $30.2 million for fiscal 2013; and revenue of $65.3 million, EBIT of $10.6 million and net income of $6.9 million for the second quarter of 2013. Full Article
Medidata Solutions Inc Issues FY 2013 Outlook; Revenue, EBIT Outlook Above Analysts' Estimates; Issues Q1 2013 Revenue, EBIT Outlook Above Estimates; Issues Q1 2013 Net Income Outlook Below Estimates
Medidata Solutions Inc announced that for fiscal 2013, it expects revenues between $265.0 and $270.0 million, Non-GAAP operating income between $57.0 and $60.0 million, based on current estimates, this would equate to GAAP operating income between $20.0 and $23.0 million. Adjusted non-GAAP net income, which includes the tax affected impact from stock-based compensation and amortization at a 40% effective tax rate, between $28.0 and $31.0 million. Based on current estimates, this would equate to GAAP net income between $10.5 and $13.5 million. For the first quarter of 2013, the Company expects revenues between $60.5 and $61.5 million, Non-GAAP operating income (EBIT) between $11.0 and $12.0 million, Based on current estimates this would equate to GAAP operating income between $4.0 and $5.0 million. Adjusted non-GAAP net income, which includes the tax effected impact from stock-based compensation and amortization at a 40% effective tax rate, between $5.0 and $6.0 million. Based on current estimates, this would equate to GAAP net income between $2.0 and $3.0 million. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $257.5 million, EBIT of $43.6 million and net income of $30.3 million for fiscal 2013; and revenue of $60.3 million, EBIT of $10.3 million and net income of $6.4 million for the first quarter of 2013. Full Article
Medidata Solutions Inc Expands Partnership With K&L Consulting Services
Medidata Solutions Inc announced that K&L Consulting Services (K&L), Inc. has expanded relationship with Medidata Solutions by achieving multiple accreditations in the Medidata Clinical Cloud. With this, K&L is accredited to provide services around the Medidata Rave system for electronic data capture (EDC) and clinical data management (CDM) as well as randomization services utilizing Medidata Balance. Full Article
Medidata Solutions Inc Raises FY 2012 Revenue Guidance; Lowers FY 2012 Earnings Guidance; Issues Q4 2012 Guidance In Line With Analysts' Estimates
Medidata Solutions Inc announced that for fiscal 2012, it expects revenues between $217.7-$219.7 million; non-GAAP operating income between $45.6-$47.1 million. Based on current estimates, this would equate to GAAP operating income between $26.1-$27.6 million; Non-GAAP net income between $28.7-$30.2 million. Based on current estimates, this would equate to GAAP net income between $15.4-$16.9 million; and adjusted non-GAAP net income, which includes the tax effected impact from stock-based compensation and amortization at a 40% effective tax rate, between $23.3-$24.8 million. For the fourth quarter of 2012, the Company expects revenues between $58.0-$60.0 million; Non-GAAP operating income between $12.5-$14.0 million. Based on current estimates this would equate to GAAP operating income between $7.5-$9.0 million; Non-GAAP net income between $7.5-$9.0 million. Based on current estimates, this would equate to GAAP net income between $4.0-$5.5 million; and adjusted non-GAAP net income, which includes the tax effected impact from stock-based compensation and amortization at a 40% effective tax rate, between $6.0-$7.5 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $218.4 million and net income of $28.2 million for fiscal 2012; and revenue of $58.1 million and net income of $9.0 million for the fourth quarter of 2012. Full Article
Medidata Solutions Inc Secures Contract
Medidata Solutions Inc announced that Mesoblast will implement Medidata Rave, including Rave Safety Gateway and Rave Targeted SDV, and Medidata Coder across its clinical studies to support the development of treatments based on its adult stem cell technology. Full Article
Medidata Solutions Inc Secures Contract From U.S. Department of Health and Human Services And Eastern Research Group, Inc.
Medidata Solutions Inc announced that the U.S. Department of Health and Human Services (HHS) and consulting firm Eastern Research Group, Inc. (ERG) have selected the comprehensive trial cost database products from Medidata Solutions to drive research into improving the clinical trial process industry-wide. Through Medidata Grants Manager and Medidata CRO Contractor, HHS will have access to Medidata’s databases containing information from over 275,000 negotiated clinical site grants and almost 9,000 outsourced R&D contracts. Full Article
Medidata Solutions Inc Raises FY 2012 Revenue Guidance; Raises Low End Of Prior FY 2012 Earnings Guidance; Issues Q3 2012 Guidance Above Analysts' Estimates
Medidata Solutions Inc announced that for fiscal 2012, it expects revenues to be between $217-$219 million, compared with prior guidance of $213-$217 million, Non-GAAP operating income is expected to be between $52.0-$54.5 million, compared with prior guidance of between $51.5-$54.5 million, GAAP operating income between $32.5-$35.0 million, Non-GAAP net income to be between $33.0-$35.5 million, compared with prior guidance of between $32.5-$35.5 million, GAAP net income between $20.0-$22.5 million, adjusted non-GAAP net income, which includes tax impact, primarily from stock-based compensation and amortization at a 40% effective tax rate, to be between $27.5-$30.0 million, compared with prior guidance of between $27.0-$30.0 million. For the third quarter of 2012, it expects revenues to be between $55.5- $56.5 million, non-GAAP operating income to be between $14.0-$15.0 million, GAAP operating income of between $9.0-$10.0 million, Non-GAAP net income to be between $8.5-$9.5 million, GAAP net income of between $5.0-$6.0 million, adjusted non-GAAP net income, which includes tax impact, primarily on stock-based compensation and amortization at a 40% effective tax rate, to be between $7.5-$8.5 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $215 million for fiscal 2012, net income of $28.3 million and revenue of $54.9 million and net income of $7.9 million for the third quarter of 2012. Full Article
Medidata Solutions Inc Raises FY 2012 Guidance; Issues Q2 2012 Guidance; Revenue, Operating Income Guidance Below Analysts' Estimates
Medidata Solutions Inc announced that for fiscal 2012, it now expects revenues to be between $213 and $217 million, non-GAAP operating income to be between $51.5 and $54.5 million. Based on current estimates, this would equate to GAAP operating income between $32.0 and $35.0 million. Non-GAAP net income is now expected to be between $32.5 and $35.5 million, GAAP net income between $19.5 and $22.5 million. For the second quarter of 2012, the Company expects revenues to be between $51.5 and $52.5 million, non-GAAP operating income to be between $10.0 and $11.0 million, GAAP operating income of $5.0 and $6.0 million, Non-GAAP net income to be between $6.0 and $7.0 million and GAAP net income of between $3.0 and $4.0 million. The Company expects adjusted non-GAAP net income, which includes tax impact, primarily on stock-based compensation and amortization at a 40% effective tax rate, to be between $5.0 and $6.0 million. According to I/B/E/S Estimates, analysts were expecting the Company to report net profit of $6.8 million and operating profit of $11.4 million on revenues of $52.8 million for the second quarter of 2012; net profit of $28.4 million, operating profit of $47.1 million on revenues of $211.5 million for the fiscal 2012. Full Article
TKL Research Selects Medidata Solutions’ Clinical Trial Management System To Drive Future Growth
TKL Research announced that it has selected Medidata CTMS, a software-as-a-service (SaaS) clinical trial management system offered by Medidata Solutions , as part of an initiative to expand its clinical trial operations. Medidata CTMS allows TKL to identify sites that can rapidly enroll the right patients by measuring actual recruitment milestones against site-forecasted times. Full Article
Medidata Solutions Inc Raises FY 2012 Revenue Guidance; Issues FY 2012 Earnings Guidance; Operating Income Guidance Above Analysts' Estimates; Issues Q1 2012 Mixed Guidance
Medidata Solutions Inc raised fiscal 2012 revenue guidance on record application services backlog. For fiscal 2012, the Company expects revenues to be between $210 and $215 million, non-GAAP operating income to be between $50.0-$53.0 million, GAAP operating income between $30.5 and $33.5 million and non-GAAP net income to be between $31.0-$34.0 million. Based on current estimates, this would equate to GAAP net income between $18.0 and $21.0 million fiscal 2012. For the first quarter of 2012, the Company expects revenues to be between $48.5 and $49.5 million, non-GAAP operating income to be between $9.0 and $10.0 million, GAAP operating income of $5.0 and $6.0 million, non-GAAP net income to be between $5.5 and $6.5 million and GAAP net income of between $3.0 and $4.0 million. The Company expects adjusted non-GAAP net income, which includes the tax impact on stock-based compensation and amortization at a 40% effective tax rate, to be between $4.5 and $5.5 million. According to I/B/E/S Estimates, analysts were expecting the Company to report net profit of $6.2 million and operating profit of $10.2 million on revenues of $47.9 million for the first quarter of 2012; net profit of $31.3 million, operating profit of $47.9 million on revenues of $205.1 million for the fiscal 2012. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
